M&A Deal Summary

Medicure Acquires Zypitamag

On September 30, 2019, Medicure acquired life science company Zypitamag from Zydus Lifesciences for 7M USD

Acquisition Highlights
  • This is Medicure’s 2nd transaction in the Life Science sector.
  • This is Medicure’s largest (disclosed) transaction.
  • This is Medicure’s 2nd transaction in the United States.

M&A Deal Summary
Date 2019-09-30
Target Zypitamag
Sector Life Science
Buyer(s) Medicure
Sellers(s) Zydus Lifesciences
Deal Type Divestiture
Deal Value 7M USD

Target

Zypitamag

United States
Zypitamag is an HMG-CoA reductase inhibitor indicated for adult patients with primary hyperlipidemia or mixed dyslipidemia as adjunctive therapy to diet, to reduce elevated total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), apolipoprotein B (Apo B), triglycerides (TG), and to increase high-density lipoprotein cholesterol (HDL-C)

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Medicure

Winnipeg, Manitoba, Canada
Category Company
Founded 1997
Sector Life Science
Revenue 22M CAD (2023)
DESCRIPTION

Medicure is a specialty pharmaceutical company focused on the development and commercialization of therapeutics for the U.S. hospital market. The Company’s current focus is in the area of acute cardiovascular care, a market served by its commercial product, AGGRASTAT (tirofiban HCl). Medicure was founded in 1997 and is based in Winnipeg, Manitoba.

DEAL STATS #
Overall 2 of 3
Sector (Life Science) 2 of 2
Type (Divestiture) 1 of 1
Country (United States) 2 of 3
Year (2019) 1 of 1
Size (of disclosed) 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-11-18 Apicore

Somerset, New Jersey, United States

Apicore, Inc. is a developer and manufacturer of specialty Active Pharmaceutical Ingredients ("APIs") and pharmaceuticals, including over 15 Abbreviated New Drug Applications ("ANDAs"), one of which, is partnered with Medicure. Apicore manufactures over 100 different API's, including over 35 for which Drug Master Files have been submitted to the FDA and 12 that are approved for commercial sale in the U.S. by customers of Apicore.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2020-12-17 Marley Drug

Winston-Salem, North Carolina, United States

Marley Drug, Inc. is a provider of an advanced operating systems include automated pill dispensing, an extended supply generic drug program, and an effective customer communication system. Marley Drug is based in Winston-Salem, North Carolina.

Buy $6M

Seller(S) 1

SELLER

Zydus Lifesciences

Ahmedabad, India
Category Company
Founded 1952
Sector Life Science
Employees23,000
Revenue 190.2B INR (2024)
DESCRIPTION

Zydus Lifesciences is a pharmaceutical company that discovers, develops,manufactures and markets a broad range of healthcare therapies. Zydus Lifesciences was formed in 1952 and is based in Ahmedabad, India.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Divestiture) 1 of 1
Country (United States) 1 of 1
Year (2019) 1 of 1
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-08-13 Windlas Healthcare Pvt.

Gurugram, India

Windlas Healthcare Pvt. Ltd. is a robust manufacturing infrastructure with a USFDA inspected oral solids manufacturing facility. Windlas Healthcare Pvt. Ltd. was founded in 2008 and is based in Gurugram, India.

Buy -
Mergr

Product

Company

Legal